Table 1.

Results of the in vitro cytotoxic activity of benzimidazoles against the HepG2 cell line.

Entry	Compound	IC50 (μM) a on HepG2 Cell Line
1	4a	> 200
2	4b	102.54
3	6	13.52
4	8a	> 200
5	8b	> 150
6	8c	> 200
7	8d	> 150
8	9a	32.53
9	10a	301.35
10	13a	158.14
11	13b	136.84
12	13c	140.11
13	13d	11.93
14	13e	86.97
15	13f	16.67
16	13g	13.90
17	13h	59.85
18	14a	25.88
19	14b	26.16
20	14c	112.35
21	14d	62.00
22	17a	1.98
23	17b	10.04
24	17c	20.18
25	17d	15.55
26	17e	24.11
27	17f	42.49
28	19a	109.47
29	19b	71.73
30	19c	133.39
31	19d	114.17
32	22a	122.93
33	22b	106.88
34	24a	80.68
35	24b	15.92
36	24c	8.73
37	Sorafenib (I)	10.99

^a IC₅₀ are presented as mean of three independent experiments.